Exact Sciences Corporation (EXAS)

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

• 
  Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now

  Zacks
• 
  Why Investors Need to Take Advantage of These 2 Retail-Wholesale Stocks Now

  Zacks

Could Exact Sciences Stock Help You Become a Millionaire?

Exact Sciences (NASDAQ: EXAS) is one of the  companies capitalizing on those opportunities. Its Cologuard test screens for colorectal cancer and has helped the company generate significant sales growth along the way. The business is promising and the company also has other tests which help screen for breast cancer and liver cancer.

Cathie Wood says AI will power the 'most massive productivity increase in history'

Cathie Wood of ARK Invest says AI will trigger an "astounding and shocking" surge in productivity.